Article citationsMore>>

Haraldsdottir, S., Janku, F., Poi, M., et al. (2018) Phase I Trial of Dabrafenib and Pazopanib in BRAF Mutated Advanced Malignancies. JCO Precision Oncology, 2, 1-19.
https://doi.org/10.1200/PO.17.00247

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top